Cargando…
Protein Kinase CK2 Expression Predicts Relapse Survival in ERα Dependent Breast Cancer, and Modulates ERα Expression in Vitro
The heterotetrameric protein kinase CK2 has been associated with oncogenic transformation, and our previous studies have shown that it may affect estrogenic signaling. Here, we investigate the role of the protein kinase CK2 in regulating ERα (estrogen receptor α) signaling in breast cancer. We deter...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730427/ https://www.ncbi.nlm.nih.gov/pubmed/26703694 http://dx.doi.org/10.3390/ijerph13010036 |
_version_ | 1782412397720371200 |
---|---|
author | Williams, Marlon D. Nguyen, Thu Carriere, Patrick P. Tilghman, Syreeta L. Williams, Christopher |
author_facet | Williams, Marlon D. Nguyen, Thu Carriere, Patrick P. Tilghman, Syreeta L. Williams, Christopher |
author_sort | Williams, Marlon D. |
collection | PubMed |
description | The heterotetrameric protein kinase CK2 has been associated with oncogenic transformation, and our previous studies have shown that it may affect estrogenic signaling. Here, we investigate the role of the protein kinase CK2 in regulating ERα (estrogen receptor α) signaling in breast cancer. We determined the correlation of CK2α expression with relapse free breast cancer patient survival utilizing Kaplan Meier Plotter (kmplot.com/analysis/) to mine breast cancer microarrays repositories. Patients were stratified according to ERα status, histological grade, and hormonal therapy. Luciferase reporter assays and flow cytometry were implemented to determine the impact of CK2 inhibition on ERE-mediated gene expression and expression of ERα protein. CK2α expression is associated with shorter relapse free survival among ERα (+) patients with grade 1 or 2 tumors, as well as among those patients receiving hormonal therapy. Biochemical inhibition of CK2 activity results in increased ER-transactivation as well as increased expression among ERα (+) and ERα (−) breast cancer cell lines. These findings suggest that CK2 may contribute to estrogen-independent cell proliferation and breast tumor progression, and may potentially serve as a biomarker and pharmacological target in breast cancer. |
format | Online Article Text |
id | pubmed-4730427 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-47304272016-02-11 Protein Kinase CK2 Expression Predicts Relapse Survival in ERα Dependent Breast Cancer, and Modulates ERα Expression in Vitro Williams, Marlon D. Nguyen, Thu Carriere, Patrick P. Tilghman, Syreeta L. Williams, Christopher Int J Environ Res Public Health Article The heterotetrameric protein kinase CK2 has been associated with oncogenic transformation, and our previous studies have shown that it may affect estrogenic signaling. Here, we investigate the role of the protein kinase CK2 in regulating ERα (estrogen receptor α) signaling in breast cancer. We determined the correlation of CK2α expression with relapse free breast cancer patient survival utilizing Kaplan Meier Plotter (kmplot.com/analysis/) to mine breast cancer microarrays repositories. Patients were stratified according to ERα status, histological grade, and hormonal therapy. Luciferase reporter assays and flow cytometry were implemented to determine the impact of CK2 inhibition on ERE-mediated gene expression and expression of ERα protein. CK2α expression is associated with shorter relapse free survival among ERα (+) patients with grade 1 or 2 tumors, as well as among those patients receiving hormonal therapy. Biochemical inhibition of CK2 activity results in increased ER-transactivation as well as increased expression among ERα (+) and ERα (−) breast cancer cell lines. These findings suggest that CK2 may contribute to estrogen-independent cell proliferation and breast tumor progression, and may potentially serve as a biomarker and pharmacological target in breast cancer. MDPI 2015-12-22 2016-01 /pmc/articles/PMC4730427/ /pubmed/26703694 http://dx.doi.org/10.3390/ijerph13010036 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Williams, Marlon D. Nguyen, Thu Carriere, Patrick P. Tilghman, Syreeta L. Williams, Christopher Protein Kinase CK2 Expression Predicts Relapse Survival in ERα Dependent Breast Cancer, and Modulates ERα Expression in Vitro |
title | Protein Kinase CK2 Expression Predicts Relapse Survival in ERα Dependent Breast Cancer, and Modulates ERα Expression in Vitro |
title_full | Protein Kinase CK2 Expression Predicts Relapse Survival in ERα Dependent Breast Cancer, and Modulates ERα Expression in Vitro |
title_fullStr | Protein Kinase CK2 Expression Predicts Relapse Survival in ERα Dependent Breast Cancer, and Modulates ERα Expression in Vitro |
title_full_unstemmed | Protein Kinase CK2 Expression Predicts Relapse Survival in ERα Dependent Breast Cancer, and Modulates ERα Expression in Vitro |
title_short | Protein Kinase CK2 Expression Predicts Relapse Survival in ERα Dependent Breast Cancer, and Modulates ERα Expression in Vitro |
title_sort | protein kinase ck2 expression predicts relapse survival in erα dependent breast cancer, and modulates erα expression in vitro |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730427/ https://www.ncbi.nlm.nih.gov/pubmed/26703694 http://dx.doi.org/10.3390/ijerph13010036 |
work_keys_str_mv | AT williamsmarlond proteinkinaseck2expressionpredictsrelapsesurvivalineradependentbreastcancerandmodulateseraexpressioninvitro AT nguyenthu proteinkinaseck2expressionpredictsrelapsesurvivalineradependentbreastcancerandmodulateseraexpressioninvitro AT carrierepatrickp proteinkinaseck2expressionpredictsrelapsesurvivalineradependentbreastcancerandmodulateseraexpressioninvitro AT tilghmansyreetal proteinkinaseck2expressionpredictsrelapsesurvivalineradependentbreastcancerandmodulateseraexpressioninvitro AT williamschristopher proteinkinaseck2expressionpredictsrelapsesurvivalineradependentbreastcancerandmodulateseraexpressioninvitro |